Search Results - "Laggai, Stephan"
-
1
Hepatocellular Carcinoma and Nuclear Paraspeckles: Induction in Chemoresistance and Prediction for Poor Survival
Published in Cellular physiology and biochemistry (2019)“…Hepatocellular carcinoma (HCC) represents the second most common cause of cancer-related deaths worldwide, not least due to its high chemoresistance. The long…”
Get full text
Journal Article -
2
The IGF2 mRNA binding protein p62/IGF2BP2-2 induces fatty acid elongation as a critical feature of steatosis[S]
Published in Journal of lipid research (01-06-2014)“…Liver-specific overexpression of the insulin-like growth factor 2 (IGF2) mRNA binding protein p62/IGF2BP2-2 induces a fatty liver, which highly expresses IGF2…”
Get full text
Journal Article -
3
IGF2 mRNA binding protein p62/IMP2-2 in hepatocellular carcinoma: antiapoptotic action is independent of IGF2/PI3K signaling
Published in American journal of physiology: Gastrointestinal and liver physiology (15-02-2013)“…The insulin-like growth factor II (IGF2) mRNA binding protein (IMP) p62/IMP2-2, originally isolated from a hepatocellular carcinoma (HCC) patient, induces a…”
Get more information
Journal Article -
4
The mRNA-binding Protein TTP/ZFP36 in Hepatocarcinogenesis and Hepatocellular Carcinoma
Published in Cancers (08-11-2019)“…Hepatic lipid deposition and inflammation represent risk factors for hepatocellular carcinoma (HCC). The mRNA-binding protein tristetraprolin (TTP, gene name )…”
Get full text
Journal Article -
5
Alterations in the hepatocyte epigenetic landscape in steatosis
Published in Epigenetics & chromatin (06-07-2023)“…Fatty liver disease or the accumulation of fat in the liver, has been reported to affect the global population. This comes with an increased risk for the…”
Get full text
Journal Article -
6
The long non-coding RNA H19 suppresses carcinogenesis and chemoresistance in hepatocellular carcinoma
Published in Cell Stress (01-10-2017)“…The long non-coding RNA (lncRNA) represents a maternally expressed and epigenetically regulated imprinted gene product and is discussed to have either…”
Get full text
Journal Article -
7
Corrigendum: Transient Hepatic Overexpression of Insulin-Like Growth Factor 2 Induces Free Cholesterol and Lipid Droplet Formation
Published in Frontiers in physiology (29-07-2016)“…[This corrects the article on p. 147 in vol. 7, PMID: 27199763.]…”
Get full text
Journal Article -
8
Rapid chromatographic method to decipher distinct alterations in lipid classes in NAFLD/NASH
Published in World journal of hepatology (27-10-2013)“…AIM: To establish a simple method to quantify lipid classes in liver diseases and to decipher the lipid profile in p62/IMP2-2/IGF2BP2-2 transgenic…”
Get full text
Journal Article -
9
First Small-Molecule Inhibitors Targeting the RNA-Binding Protein IGF2BP2/IMP2 for Cancer Therapy
Published in ACS chemical biology (18-02-2022)“…The RNA-binding protein IGF2BP2/IMP2/VICKZ2/p62 is overexpressed in several tumor entities, promotes tumorigenesis and tumor progression, and has been…”
Get full text
Journal Article -
10
Lack of Kupffer cell depletion in diethylnitrosamine-induced hepatic inflammation
Published in Journal of hepatology (01-04-2019)Get full text
Journal Article -
11
Hepatic hepcidin expression is decreased in cirrhosis and HCC
Published in Journal of hepatology (01-04-2015)Get full text
Journal Article -
12
-
13
Hepatic interleukin-6 production is maintained during endotoxin tolerance and facilitates lipid accumulation
Published in Immunobiology (1979) (01-06-2017)“…Graphical abstract…”
Get full text
Journal Article -
14
THU-470-The mRNA-binding protein tristetraprolin promotes hepatocarcinogenesis but inhibits tumour progression in liver cancer
Published in Journal of hepatology (01-04-2019)Get full text
Journal Article -
15
IMP2/IGF2BP2 expression, but not IMP1 and IMP3, predicts poor outcome in patients and high tumor growth rate in xenograft models of gallbladder cancer
Published in Oncotarget (27-10-2017)“…Overexpression of the oncofetal insulin-like growth factor 2 mRNA-binding protein 2 (IMP2/IGF2BP2) has been described in different cancer types. Gallbladder…”
Get full text
Journal Article -
16
Lipid Metabolism Signatures in NASH-Associated HCC-Letter
Published in Cancer research (Chicago, Ill.) (15-05-2014)Get full text
Journal Article -
17
Erratum to “Hepatic hepcidin expression is decreased in cirrhosis and HCC” [J Hepatol 2015;62:977–979]
Published in Journal of hepatology (01-08-2015)Get full text
Journal Article -
18
Transient Hepatic Overexpression of Insulin-Like Growth Factor 2 Induces Free Cholesterol and Lipid Droplet Formation
Published in Frontiers in physiology (25-04-2016)“…Although insulin-like growth factor 2 (IGF2) has been reported to be overexpressed in steatosis and steatohepatitis, a causal role of IGF2 in steatosis…”
Get full text
Journal Article